Identification and characterization of persistent human erythrovirus infection in blood donor samples
The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened. Sensitive qualitative and real-time quantitative PCR assays revealed a higher prevalence of persistent infection with the simultaneous presen...
Saved in:
| Published in: | Journal of virology Vol. 78; no. 22; p. 12169 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.11.2004
|
| Subjects: | |
| ISSN: | 0022-538X |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened. Sensitive qualitative and real-time quantitative PCR assays revealed a higher prevalence of persistent infection with the simultaneous presence of immunoglobulin G (IgG) and viral DNA (0.55 to 1.3%) than previously reported. This condition was characterized by a low viral load (median, 558 IU/ml; range, 42 to 135,000 IU/ml), antibody-complexed virus, free specific IgG, and potentially infectious free virus. Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Malawi, and South Africa. In contrast, only human erythrovirus genotype 3 (erythrovirus variant V9) was prevalent in Ghana. Genotype 3 had considerable genetic diversity, clustering in two probable subtypes. Genotype 1-based antibody assays failed to detect 38.5% of Ghanaian samples containing antibodies to genotype 3 virus but did not fail to detect cases of persistent infection. This study indicates a potential African origin of genotype 3 human erythrovirus and considerable shortcomings in the tools currently used to diagnose erythrovirus infection. |
|---|---|
| AbstractList | The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened. Sensitive qualitative and real-time quantitative PCR assays revealed a higher prevalence of persistent infection with the simultaneous presence of immunoglobulin G (IgG) and viral DNA (0.55 to 1.3%) than previously reported. This condition was characterized by a low viral load (median, 558 IU/ml; range, 42 to 135,000 IU/ml), antibody-complexed virus, free specific IgG, and potentially infectious free virus. Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Malawi, and South Africa. In contrast, only human erythrovirus genotype 3 (erythrovirus variant V9) was prevalent in Ghana. Genotype 3 had considerable genetic diversity, clustering in two probable subtypes. Genotype 1-based antibody assays failed to detect 38.5% of Ghanaian samples containing antibodies to genotype 3 virus but did not fail to detect cases of persistent infection. This study indicates a potential African origin of genotype 3 human erythrovirus and considerable shortcomings in the tools currently used to diagnose erythrovirus infection.The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened. Sensitive qualitative and real-time quantitative PCR assays revealed a higher prevalence of persistent infection with the simultaneous presence of immunoglobulin G (IgG) and viral DNA (0.55 to 1.3%) than previously reported. This condition was characterized by a low viral load (median, 558 IU/ml; range, 42 to 135,000 IU/ml), antibody-complexed virus, free specific IgG, and potentially infectious free virus. Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Malawi, and South Africa. In contrast, only human erythrovirus genotype 3 (erythrovirus variant V9) was prevalent in Ghana. Genotype 3 had considerable genetic diversity, clustering in two probable subtypes. Genotype 1-based antibody assays failed to detect 38.5% of Ghanaian samples containing antibodies to genotype 3 virus but did not fail to detect cases of persistent infection. This study indicates a potential African origin of genotype 3 human erythrovirus and considerable shortcomings in the tools currently used to diagnose erythrovirus infection. The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened. Sensitive qualitative and real-time quantitative PCR assays revealed a higher prevalence of persistent infection with the simultaneous presence of immunoglobulin G (IgG) and viral DNA (0.55 to 1.3%) than previously reported. This condition was characterized by a low viral load (median, 558 IU/ml; range, 42 to 135,000 IU/ml), antibody-complexed virus, free specific IgG, and potentially infectious free virus. Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Malawi, and South Africa. In contrast, only human erythrovirus genotype 3 (erythrovirus variant V9) was prevalent in Ghana. Genotype 3 had considerable genetic diversity, clustering in two probable subtypes. Genotype 1-based antibody assays failed to detect 38.5% of Ghanaian samples containing antibodies to genotype 3 virus but did not fail to detect cases of persistent infection. This study indicates a potential African origin of genotype 3 human erythrovirus and considerable shortcomings in the tools currently used to diagnose erythrovirus infection. |
| Author | Candotti, Daniel Etiz, Nermin Allain, Jean-Pierre Parsyan, Armen |
| Author_xml | – sequence: 1 givenname: Daniel surname: Candotti fullname: Candotti, Daniel email: dc241@cam.ac.uk organization: National Blood Service, Cambridge Blood Centre, Long Road, Cambridge CB2 2PT, United Kingdom. dc241@cam.ac.uk – sequence: 2 givenname: Nermin surname: Etiz fullname: Etiz, Nermin – sequence: 3 givenname: Armen surname: Parsyan fullname: Parsyan, Armen – sequence: 4 givenname: Jean-Pierre surname: Allain fullname: Allain, Jean-Pierre |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15507603$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kD1PwzAYhD0U0Q_4C8hiYEt4XyexkxFVfBRVYgHEFjm2oxoldrATpPLrKVCWO93p0Q23JDPnnSHkEiFFZOX14-smFWXKWIoMeZUc9CcC5DOyAGAsKbLybU6WMb4DYJ7z_JTMsShAcMgWxGy0caNtrZKj9Y5Kp6naySDVaIL9-it9SwcToo3jgaW7qZeOmrAfd8F_2jBFal1r1C9qHW067zXV3vlAo-yHzsQzctLKLprzo6_Iy93t8_oh2T7db9Y320QVCGOiERvOK1WhQihRY6FkhlXWIGhQQkoQQjHeYqaEyLTIeKOgaqAQ0KAAzlbk6m93CP5jMnGsexuV6TrpjJ9izQVgBgwO4MURnJre6HoItpdhX_8fw74BbAZopg |
| CitedBy_id | crossref_primary_10_1128_JCM_44_4_1367_1375_2006 crossref_primary_10_1159_000445195 crossref_primary_10_1016_j_jviromet_2008_03_023 crossref_primary_10_1111_j_1537_2995_2007_01459_x crossref_primary_10_1128_JCM_00820_13 crossref_primary_10_1542_peds_2017_1435 crossref_primary_10_1016_j_jcv_2012_04_023 crossref_primary_10_1002_jmv_21947 crossref_primary_10_1016_j_tracli_2010_04_002 crossref_primary_10_1128_JCM_44_2_604_606_2006 crossref_primary_10_1111_j_1423_0410_2009_01170_x crossref_primary_10_1002_jmv_23294 crossref_primary_10_3390_v13040540 crossref_primary_10_5402_2013_898730 crossref_primary_10_1186_s12985_015_0326_0 crossref_primary_10_1002_jmv_25195 crossref_primary_10_1111_j_1537_2995_2007_01503_x crossref_primary_10_4103_NJM_NJM_6_20 crossref_primary_10_1002_jmv_24028 crossref_primary_10_1002_jmv_24425 crossref_primary_10_1002_jmv_70443 crossref_primary_10_1128_JVI_01003_08 crossref_primary_10_1111_j_1537_2995_2007_01237_x crossref_primary_10_1111_j_1537_2995_2012_03949_x crossref_primary_10_1097_MD_0000000000019832 crossref_primary_10_1111_trf_17630 crossref_primary_10_1111_1469_0691_12058 crossref_primary_10_1016_j_virol_2009_04_016 crossref_primary_10_1016_j_tracli_2006_03_016 crossref_primary_10_1016_j_meegid_2017_11_021 crossref_primary_10_1111_j_1537_2995_2007_01341_x crossref_primary_10_1038_s41467_024_53794_1 crossref_primary_10_7554_eLife_72791 crossref_primary_10_1002_jmv_21289 crossref_primary_10_1590_1806_9282_63_03_224 crossref_primary_10_1111_j_1537_2995_2010_02995_x crossref_primary_10_1002_jmv_24560 crossref_primary_10_1186_1471_2334_10_88 crossref_primary_10_1002_jmv_24169 crossref_primary_10_1182_blood_2009_06_225706 crossref_primary_10_1128_JCM_00610_09 crossref_primary_10_4103_ijmr_IJMR_1816_16 crossref_primary_10_14412_1996_7012_2025_2_113_118 crossref_primary_10_1002_jmv_23358 crossref_primary_10_1128_JVI_00684_10 crossref_primary_10_1016_j_jcv_2011_06_017 crossref_primary_10_1038_srep17226 crossref_primary_10_1111_j_1423_0410_2007_00957_x crossref_primary_10_1016_j_clinmicnews_2005_07_006 crossref_primary_10_1159_000455124 crossref_primary_10_1111_j_1537_2995_2008_01704_x crossref_primary_10_1128_JVI_79_8_5238_5239_2005 crossref_primary_10_1111_j_1537_2995_2007_01393_x crossref_primary_10_1016_j_tracli_2015_11_006 crossref_primary_10_2350_14_05_1495_OA_1 crossref_primary_10_1111_j_1537_2995_2010_02591_x crossref_primary_10_1073_pnas_0602259103 crossref_primary_10_1111_1348_0421_13044 crossref_primary_10_1128_JCM_02270_13 crossref_primary_10_1080_15321819_2023_2167520 crossref_primary_10_5812_archcid_97856 crossref_primary_10_2217_17460794_2_4_377 crossref_primary_10_1016_j_jviromet_2015_03_006 crossref_primary_10_1186_1471_2334_13_375 crossref_primary_10_1016_j_tracli_2009_09_001 crossref_primary_10_1128_CMR_00040_16 crossref_primary_10_1111_j_1423_0410_2007_00992_x crossref_primary_10_1038_s41598_020_72657_5 crossref_primary_10_1016_j_heliyon_2020_e03869 crossref_primary_10_1111_bjh_12060 crossref_primary_10_1111_j_1537_2995_2007_01235_x crossref_primary_10_1128_JVI_02713_06 crossref_primary_10_1016_j_virol_2009_08_044 crossref_primary_10_1111_j_1537_2995_2012_03573_x crossref_primary_10_7554_eLife_68612 crossref_primary_10_1111_j_1537_2995_2011_03067_x crossref_primary_10_1590_S0074_02762005000800005 crossref_primary_10_1016_j_cca_2006_04_018 crossref_primary_10_1016_S2221_1691_13_60037_4 crossref_primary_10_1016_j_jviromet_2007_10_004 crossref_primary_10_1007_s12311_009_0126_4 crossref_primary_10_1128_JVI_01304_10 crossref_primary_10_1111_j_1537_2995_2005_00610_x crossref_primary_10_1111_j_1537_2995_2010_02780_x crossref_primary_10_1016_j_idc_2005_09_002 crossref_primary_10_1016_j_mcp_2017_08_005 crossref_primary_10_1111_j_1365_3148_2007_00765_x crossref_primary_10_1128_JCM_01201_09 crossref_primary_10_1016_j_prp_2008_04_004 crossref_primary_10_1002_jmv_25450 crossref_primary_10_1016_j_mjafi_2012_11_009 crossref_primary_10_1111_j_1537_2995_2006_00952_x crossref_primary_10_1002_jmv_25453 crossref_primary_10_1016_j_ijid_2017_09_018 crossref_primary_10_1016_j_patbio_2008_02_005 crossref_primary_10_4103_ajts_ajts_185_20 crossref_primary_10_1002_rmv_648 crossref_primary_10_1016_j_jcv_2006_01_011 crossref_primary_10_1128_JVI_00471_08 crossref_primary_10_1002_jmv_21018 crossref_primary_10_1016_j_xagr_2025_100514 crossref_primary_10_1111_j_1537_2995_2009_02160_x crossref_primary_10_1016_j_berh_2006_08_007 crossref_primary_10_1016_j_jcv_2013_08_007 crossref_primary_10_1111_j_1365_3148_2007_00776_x crossref_primary_10_1002_jmv_23557 crossref_primary_10_1128_CMR_00130_18 crossref_primary_10_1128_JVI_79_22_14197_14206_2005 crossref_primary_10_1146_annurev_virology_111821_123859 crossref_primary_10_1007_s00705_009_0482_x crossref_primary_10_2217_fvl_11_120 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/JVI.78.22.12169-12178.2004 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| ExternalDocumentID | 15507603 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAYJJ ABPPZ ACGFO ACNCT ADBBV AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A NPM O9- OHT OK1 P2P PKN RHF RHI RNS RPM RSF TR2 UCJ UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM 7X8 AAFWJ AAGFI AFPKN |
| ID | FETCH-LOGICAL-c510t-d11b669c91c1081d15ca3193b10d0c7aa077c26f13c773d736bc09b0570b17062 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 149 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000224781400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0022-538X |
| IngestDate | Sun Nov 09 09:29:42 EST 2025 Wed Feb 19 01:49:26 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 22 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c510t-d11b669c91c1081d15ca3193b10d0c7aa077c26f13c773d736bc09b0570b17062 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://doi.org/10.1128/JVI.78.22.12169-12178.2004 |
| PMID | 15507603 |
| PQID | 67013020 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_67013020 pubmed_primary_15507603 |
| PublicationCentury | 2000 |
| PublicationDate | 2004-11-01 |
| PublicationDateYYYYMMDD | 2004-11-01 |
| PublicationDate_xml | – month: 11 year: 2004 text: 2004-11-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of virology |
| PublicationTitleAlternate | J Virol |
| PublicationYear | 2004 |
| References | 12393691 - Blood. 2003 Mar 15;101(6):2419-25 11431751 - Hepatology. 2001 Jul;34(1):194-203 14736825 - J Mol Diagn. 2004 Feb;6(1):37-41 9784661 - Vox Sang. 1998;75(2):97-102 11285571 - J Med Virol. 2001 May;64(1):67-73 3339634 - J Med Microbiol. 1988 Feb;25(2):151-3 7594699 - J Infect Dis. 1995 Dec;172(6):1431-6 9892405 - J Med Virol. 1999 Feb;57(2):179-85 11778063 - Transfusion. 2001 Dec;41(12):1500-4 10729805 - Vox Sang. 2000;78(1):7-12 12097253 - Clin Microbiol Rev. 2002 Jul;15(3):485-505 8211491 - S Afr Med J. 1993 Jul;83(7):505-6 10405389 - J Clin Microbiol. 1999 Aug;37(8):2483-7 15795309 - J Virol. 2005 Apr;79(8):5238-9; author reply 5239 12359439 - Virology. 2002 Sep 30;301(2):374-80 11724854 - J Clin Microbiol. 2001 Dec;39(12):4413-9 1716693 - J Virol. 1991 Oct;65(10):5485-90 7684458 - J Virol. 1993 Jun;67(6):3004-9 11398810 - Viral Immunol. 2001;14(2):151-8 11125172 - J Gen Virol. 2001 Jan;82(Pt 1):191-9 15158067 - J Virol Methods. 2004 Jun 1;118(1):39-47 9971777 - J Virol. 1999 Mar;73(3):1974-9 11880419 - J Clin Microbiol. 2002 Mar;40(3):933-6 11161258 - Transfusion. 2001 Jan;41(1):130-5 8432819 - J Clin Microbiol. 1993 Feb;31(2):323-8 9892404 - J Med Virol. 1999 Feb;57(2):174-8 8578732 - Vox Sang. 1995;69(3):206-12 11115697 - Vaccine. 2000 Nov 22;19(7-8):758-63 11505436 - J Med Virol. 2001 Sep;65(1):1-5 15131163 - J Clin Microbiol. 2004 May;42(5):2013-9 12927746 - J Clin Virol. 2003 Sep;28(1):1-13 10630969 - J Med Virol. 2000 Mar;60(3):347-52 12441066 - Virology. 2002 Oct 25;302(2):224-8 8547113 - Br J Haematol. 1995 Dec;91(4):1017-8 12421221 - Transfusion. 2002 Nov;42(11):1473-81 10680740 - J Clin Virol. 2000 Feb;16(1):49-54 12559017 - Transfusion. 2003 Feb;43(2):215-25 11222696 - J Virol. 2001 Mar;75(6):2729-40 12186896 - J Virol. 2002 Sep;76(18):9124-34 2551923 - J Clin Invest. 1989 Oct;84(4):1114-23 11536245 - J Med Virol. 2001 Oct;65(2):362-7 12757504 - Vox Sang. 2003 May;84(4):300-7 14692974 - Transfusion. 2004 Jan;44(1):97-103 11782935 - J Med Virol. 2002 Feb;66(2):246-52 |
| References_xml | – reference: 8578732 - Vox Sang. 1995;69(3):206-12 – reference: 11505436 - J Med Virol. 2001 Sep;65(1):1-5 – reference: 11115697 - Vaccine. 2000 Nov 22;19(7-8):758-63 – reference: 12559017 - Transfusion. 2003 Feb;43(2):215-25 – reference: 11880419 - J Clin Microbiol. 2002 Mar;40(3):933-6 – reference: 7684458 - J Virol. 1993 Jun;67(6):3004-9 – reference: 14692974 - Transfusion. 2004 Jan;44(1):97-103 – reference: 12927746 - J Clin Virol. 2003 Sep;28(1):1-13 – reference: 10405389 - J Clin Microbiol. 1999 Aug;37(8):2483-7 – reference: 9971777 - J Virol. 1999 Mar;73(3):1974-9 – reference: 15795309 - J Virol. 2005 Apr;79(8):5238-9; author reply 5239 – reference: 11222696 - J Virol. 2001 Mar;75(6):2729-40 – reference: 3339634 - J Med Microbiol. 1988 Feb;25(2):151-3 – reference: 12186896 - J Virol. 2002 Sep;76(18):9124-34 – reference: 12393691 - Blood. 2003 Mar 15;101(6):2419-25 – reference: 11431751 - Hepatology. 2001 Jul;34(1):194-203 – reference: 12441066 - Virology. 2002 Oct 25;302(2):224-8 – reference: 12421221 - Transfusion. 2002 Nov;42(11):1473-81 – reference: 9892405 - J Med Virol. 1999 Feb;57(2):179-85 – reference: 10729805 - Vox Sang. 2000;78(1):7-12 – reference: 11778063 - Transfusion. 2001 Dec;41(12):1500-4 – reference: 8211491 - S Afr Med J. 1993 Jul;83(7):505-6 – reference: 11536245 - J Med Virol. 2001 Oct;65(2):362-7 – reference: 9892404 - J Med Virol. 1999 Feb;57(2):174-8 – reference: 12097253 - Clin Microbiol Rev. 2002 Jul;15(3):485-505 – reference: 11724854 - J Clin Microbiol. 2001 Dec;39(12):4413-9 – reference: 14736825 - J Mol Diagn. 2004 Feb;6(1):37-41 – reference: 15158067 - J Virol Methods. 2004 Jun 1;118(1):39-47 – reference: 11398810 - Viral Immunol. 2001;14(2):151-8 – reference: 9784661 - Vox Sang. 1998;75(2):97-102 – reference: 12757504 - Vox Sang. 2003 May;84(4):300-7 – reference: 2551923 - J Clin Invest. 1989 Oct;84(4):1114-23 – reference: 10630969 - J Med Virol. 2000 Mar;60(3):347-52 – reference: 8547113 - Br J Haematol. 1995 Dec;91(4):1017-8 – reference: 11125172 - J Gen Virol. 2001 Jan;82(Pt 1):191-9 – reference: 15131163 - J Clin Microbiol. 2004 May;42(5):2013-9 – reference: 11782935 - J Med Virol. 2002 Feb;66(2):246-52 – reference: 12359439 - Virology. 2002 Sep 30;301(2):374-80 – reference: 8432819 - J Clin Microbiol. 1993 Feb;31(2):323-8 – reference: 10680740 - J Clin Virol. 2000 Feb;16(1):49-54 – reference: 11285571 - J Med Virol. 2001 May;64(1):67-73 – reference: 1716693 - J Virol. 1991 Oct;65(10):5485-90 – reference: 7594699 - J Infect Dis. 1995 Dec;172(6):1431-6 – reference: 11161258 - Transfusion. 2001 Jan;41(1):130-5 |
| SSID | ssj0014464 |
| Score | 2.235863 |
| Snippet | The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened.... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 12169 |
| SubjectTerms | Amino Acid Sequence Antibodies, Viral - blood Blood Donors Capsid Proteins - immunology DNA, Viral - blood Erythrovirus - genetics Erythrovirus - immunology Erythrovirus - isolation & purification Humans Molecular Sequence Data Parvoviridae Infections - virology |
| Title | Identification and characterization of persistent human erythrovirus infection in blood donor samples |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/15507603 https://www.proquest.com/docview/67013020 |
| Volume | 78 |
| WOSCitedRecordID | wos000224781400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB6qVfDivtR1Dl5TZzJpJgFBRCwqWHpQya0ks0Avk5q0hf5738uiJ_HgJSSHQJi8ffk-Qq7BZxmbisyLA668ILLaAz8jPQMJs42NAZdoK7IJORpFSRKPO-S23YXBscrWJlaGWucKa-Q3oax6bOxu9ukhZxT2VhsCjTXSFRDIoEzL5KeHAIlO0GKFg1onDeQoGOSbl4_nvoz6vo_gCiHyAXB8ZBVd2y-BZuVwhjv_-9Rdst0EmvS-low90jFun2zW1JOrA2LqDV3blOxo6jRV3-DN9W4mzS2dYT0NJMHNaUXnR02xQmqF5bRYlLQd5XJwR6sZeKpzlxe0TBF1uDwk78PHt4cnr6Fc8BQo59zTnGdhGKuYKw7BguYDlYKSiowzzZRMUyal8kPLhZJSaCnCTLE4g6CPZQjE4x-RdZc7c0LogKkg9jG-wtZmwLPIikwFQmgVBNKaHrlqT28CIo19itSZfFFO2vPrkeP6B0xmNfLGBPMpGTJx-ue7Z2SrhmTEYsk56VpQZnNBNtRyPi2Ly0pS4Doav34BJlrHZQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+and+characterization+of+persistent+human+erythrovirus+infection+in+blood+donor+samples&rft.jtitle=Journal+of+virology&rft.au=Candotti%2C+Daniel&rft.au=Etiz%2C+Nermin&rft.au=Parsyan%2C+Armen&rft.au=Allain%2C+Jean-Pierre&rft.date=2004-11-01&rft.issn=0022-538X&rft.volume=78&rft.issue=22&rft.spage=12169&rft_id=info:doi/10.1128%2FJVI.78.22.12169-12178.2004&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |